284 related articles for article (PubMed ID: 33987346)
21. Phase II Study of High-Dose Pemetrexed Plus Cisplatin as First-Line Chemotherapy In the Treatment of Patients with Brain Metastases from Lung Adenocarcinoma.
He Q; Wang Y; Zou P; Wang Y; Xiu C; Zhang H; Chi N; Zou H; Xu J; Zhou S; Tao R
World Neurosurg; 2017 Mar; 99():758-762. PubMed ID: 27060518
[TBL] [Abstract][Full Text] [Related]
22. Whole-Brain Radiotherapy Can Improve the Survival of Patients with Multiple Brain Metastases from Non-Small Cell Lung Cancer Treated by Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors.
Chen C; Wu Y; Liu BL; Wang HW; Ma JH; Zhou JY
Cancer Manag Res; 2020; 12():11333-11340. PubMed ID: 33192093
[TBL] [Abstract][Full Text] [Related]
23. Examination of the predictive factors of the response to whole brain radiotherapy for brain metastases from lung cancer using MRI.
Aoki S; Kanda T; Matsutani N; Seki N; Kawamura M; Furui S; Yamashita H
Oncol Lett; 2017 Jul; 14(1):1073-1079. PubMed ID: 28693276
[TBL] [Abstract][Full Text] [Related]
24. Perilesional edema diameter associated with brain metastases as a predictive factor of response to radiotherapy in non-small cell lung cancer.
Arrieta O; Bolaño-Guerra LM; Caballé-Pérez E; Lara-Mejía L; Turcott JG; Gutiérrez S; Lozano-Ruiz F; Cabrera-Miranda L; Arroyave-Ramírez AM; Maldonado-Magos F; Corrales L; Martín C; Gómez-García AP; Cacho-Díaz B; Cardona AF
Front Oncol; 2023; 13():1251620. PubMed ID: 37916162
[TBL] [Abstract][Full Text] [Related]
25. Upfront radiosurgery plus targeted agents followed by active brain control using radiosurgery delays neurological death in non-small cell lung cancer with brain metastasis.
Lee SW; Kim YS; Sung SY; Kwak YK; Kang YN; Jang JS; Kang JH; Hong SH; Kim SJ; Jung SL
Clin Exp Metastasis; 2020 Apr; 37(2):353-363. PubMed ID: 32008137
[TBL] [Abstract][Full Text] [Related]
26. Role of perilesional edema and tumor volume in the prognosis of non-small cell lung cancer (NSCLC) undergoing radiosurgery (SRS) for brain metastases.
Nardone V; Nanni S; Pastina P; Vinciguerra C; Cerase A; Correale P; Guida C; Giordano A; Tini P; Reginelli A; Cappabianca S; Pirtoli L
Strahlenther Onkol; 2019 Aug; 195(8):734-744. PubMed ID: 31123785
[TBL] [Abstract][Full Text] [Related]
27. Bevacizumab-based treatment as salvage therapy in patients with recurrent symptomatic brain metastases.
Berghoff AS; Breckwoldt MO; Riedemann L; Karimian-Jazi K; Loew S; Schlieter F; Furtner J; Cinci M; Thomas M; Strowitzki MJ; Marmé F; Michel LL; Schmidt T; Jäger D; Bendszus M; Preusser M; Wick W; Winkler F
Neurooncol Adv; 2020; 2(1):vdaa038. PubMed ID: 32642693
[TBL] [Abstract][Full Text] [Related]
28. Can upfront systemic chemotherapy replace stereotactic radiosurgery or whole brain radiotherapy in the treatment of non-small cell lung cancer patients with asymptomatic brain metastases?
Kim KH; Lee J; Lee JI; Nam DH; Kong DS; Ahn YC; Park HC; Kwon OJ; Kim H; Chang MH; Yi SY; Ji SH; Park YH; Ahn JS; Park K; Ahn MJ
Lung Cancer; 2010 May; 68(2):258-63. PubMed ID: 19592127
[TBL] [Abstract][Full Text] [Related]
29. Anti-PD1 Therapy Plus Whole-Brain Radiation Therapy May Prolong PFS in Selected Non-Small Cell Lung Cancer Patients with Brain Metastases: A Retrospective Study.
Khan M; Zhao Z; Li X; Liao G
Int J Gen Med; 2021; 14():8903-8918. PubMed ID: 34858054
[TBL] [Abstract][Full Text] [Related]
30. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
[TBL] [Abstract][Full Text] [Related]
31. First-line epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor alone or with whole-brain radiotherapy for brain metastases in patients with EGFR-mutated lung adenocarcinoma.
Chen Y; Yang J; Li X; Hao D; Wu X; Yang Y; He C; Wang W; Wang J
Cancer Sci; 2016 Dec; 107(12):1800-1805. PubMed ID: 27627582
[TBL] [Abstract][Full Text] [Related]
32. Brain metastases as the primary site of relapse in two randomized phase III pemetrexed trials in advanced non-small-cell lung cancer.
Ortuzar W; Hanna N; Pennella E; Peng G; Langer C; Monberg M; Scagliotti G
Clin Lung Cancer; 2012 Jan; 13(1):24-30. PubMed ID: 21831719
[TBL] [Abstract][Full Text] [Related]
33. Survival and prognostic factors in patients undergoing the resection of solitary brain metastasis from non-small cell lung cancer: a retrospective cohort study.
Xu M; Song K; Zhou Z; Yu Z; Lv Y; Xu H
J Thorac Dis; 2022 Oct; 14(10):4113-4124. PubMed ID: 36389303
[TBL] [Abstract][Full Text] [Related]
34. Optimizing Whole Brain Radiotherapy Treatment and Dose for Patients With Brain Metastases From Small Cell Lung Cancer.
Li H; Li W; Qi C; Zhou L; Wen F; Qu Y; Yu H
Front Oncol; 2021; 11():726613. PubMed ID: 34760692
[TBL] [Abstract][Full Text] [Related]
35. Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.
Drugs R D; 2005; 6(3):178-85. PubMed ID: 15869322
[TBL] [Abstract][Full Text] [Related]
36. Comparing the efficacy of concurrent EGFR-TKI and whole-brain radiotherapy vs EGFR-TKI alone as a first-line therapy for advanced
He ZY; Li MF; Lin JH; Lin D; Lin RJ
Cancer Manag Res; 2019; 11():2129-2138. PubMed ID: 30936745
[TBL] [Abstract][Full Text] [Related]
37. Anlotinib Combined with Cranial Radiotherapy for Non-Small Cell Lung Cancer Patients with Brain Metastasis: A Retrospectively, Control Study.
He Z; Liu J; Ma Y; Jiang H; Cui Z; Wang G; Wu Y; Liu J; Cai X; Qian J; Huang J; Zhang H; Li H
Cancer Manag Res; 2021; 13():6101-6111. PubMed ID: 34377028
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of apatinib combined with whole-brain radiation therapy with a simultaneous integrated boost for brain metastases from non-small cell lung cancer: a multicenter retrospective study.
Ma J; Bi J; Tuo X; Pi G; Li Y; Li Y; Zeng F; Gong H; Hu D; Han G
J Thorac Dis; 2022 Feb; 14(2):455-463. PubMed ID: 35280489
[TBL] [Abstract][Full Text] [Related]
39. [Timing of Whole Brain Radiotherapy on Survival of Patients with EGFR-mutated
Non-small Cell Lung Cancer and Brain Metastases].
Liu G; Zhang X; Tian C; Xia G; Liu P; Zhang Q; Li X; Zhang H; Qin N; Wang J; Zhang S
Zhongguo Fei Ai Za Zhi; 2016 Aug; 19(8):501-7. PubMed ID: 27561798
[TBL] [Abstract][Full Text] [Related]
40. Impact of Deferring Radiation Therapy in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Who Develop Brain Metastases.
Magnuson WJ; Yeung JT; Guillod PD; Gettinger SN; Yu JB; Chiang VL
Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):673-9. PubMed ID: 27034176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
